Browsing: GSK

Investing.com — Shares of GSK fell over 3% following its third-quarter 2024 earnings, as investors reacted to underwhelming sales figures…

By Yadarisa Shabong and Maggie Fick (Reuters) -GSK on Wednesday said its vaccine sales would fall this year, after a…

GSK has agreed to pay up to $2.2 billion to settle most lawsuits in US state courts claiming that a discontinued…

GSK (GSK) reported robust earnings for the first quarter, with a 13% increase in sales to £7.4 billion and significant…

By Eva Mathews(Reuters) -GSK raised its full-year profit forecast on Wednesday on strong demand for vaccines and specialty medicines though…